BiotechTube

Atezolizumab + Tocilizumab + Etrumadenant

Phase 2Recruiting
0 watching 0 views this week⚡ Active
47
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Prostate Adenocarcinoma

Conditions

Prostate Adenocarcinoma, Prostate Cancer, Localized Prostate Cancer

Trial Timeline

Oct 30, 2019 → Apr 30, 2026

NCT ID
NCT03821246

About Atezolizumab + Tocilizumab + Etrumadenant

Atezolizumab + Tocilizumab + Etrumadenant is a phase 2 stage product being developed by Arcus Biosciences for Prostate Adenocarcinoma. The current trial status is recruiting. This product is registered under clinical trial identifier NCT03821246. Target conditions include Prostate Adenocarcinoma, Prostate Cancer, Localized Prostate Cancer.

Hype Score Breakdown

Clinical
17
Activity
12
Company
5
Novelty
5
Community
5

Clinical Trials (1)

NCT IDPhaseStatus
NCT03821246Phase 2Recruiting

Competing Products

20 competing products in Prostate Adenocarcinoma

See all competitors
ProductCompanyStageHype Score
NBTXR3 activated by IMRT only + NBTXR3 activated by Brachytherapy & IMRTNanobiotixPhase 1/2
36
PemetrexedEli LillyPhase 2
52
5 mg Tadalafil + Placebo + 0.2 mg TamsulosinEli LillyPhase 3
77
SRF617 + etrumadenant + zimberelimabCoherus BioSciencesPhase 2
44
Abemaciclib + Placebo + Abiraterone acetate + PrednisoneEli LillyPhase 2/3
65
eFT508eFFECTOR TherapeuticsPhase 2
44
EnhertuDaiichi SankyoPhase 2
52
Ifinatamab deruxtecan + Docetaxel + Prednisone + Rescue MedicationDaiichi SankyoPhase 3
77
exatecan mesylateDaiichi SankyoPhase 2
52
PLX3397Daiichi SankyoPhase 2
52
Valemetostat + DarolutamideDaiichi SankyoPhase 1
33
Enzalutamide + Placebo + Androgen deprivation therapy (ADT)Astellas PharmaPhase 3
77
EnzalutamideAstellas PharmaPhase 2
52
Enzalutamide + Docetaxel + Prednisolone + PlaceboAstellas PharmaPhase 3
77
EnzalutamideAstellas PharmaPhase 2
52
Enzalutamide + Metformin HydrochlorideAstellas PharmaPhase 1
33
degarelix + GoserelinAstellas PharmaPhase 3
77
Enzalutamide, 160mg, 40 mg soft capsules, once dailyAstellas PharmaPre-clinical
23
enzalutamide + abiraterone acetate + prednisoneAstellas PharmaPhase 2
52
enzalutamide + abiraterone acetate + prednisone + Leuprolide acetateAstellas PharmaPhase 2
52

Other Products from Arcus Biosciences

Casdatifan + Cabozantinib + PlaceboPhase 3
72
Quemliclustat + Placebo + Nab-paclitaxel + GemcitabinePhase 3
72
Zimberelimab + Domvanalimab + FLOT (Fluorouracil+Leucovorin+Oxaliplatin+Docetaxel)Phase 2
47
Etrumadenant (AB928) + FOLFOX regimen + Zimberelimab (AB122)Phase 2
47
Zimberelimab + DomvanalimabPhase 2
47